Weight Gain in PLWH: An Increasing Concern

Volume 7, Issue 9

Weight Gain in PLWH: An Increasing Concern

In this issue:

Obesity among people living with HIV is on the rise. What’s causing it? Is it a side effect of ART? From which regimens? What do we know and what can clinicians do about it?

Join Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University as we explore those and other questions about weight gain in people living with HIV in this issue of eHIV Review.

Learning objectives:

Identify the ART medications that have been implicated in weight gain.
Discuss the controversy over whether weight gain that has been associated with ART agents is caused by them.

Author:

Todd Brown, MD, PhD

Professor of Medicine and Epidemiology
Johns Hopkins University
Baltimore, MD

Guest Faculty Disclosures

Dr. Brown has indicated that he has received consulting fees from Merck & Co., Inc., ViiV Healthcare, Gilead Sciences, Inc., and Johnson and Johnson. He has also received grant/research support from Theratechnologies.

Unlabeled/Unapproved Uses

Dr. Brown has indicated that there will be no references to the unlabeled or unapproved uses of any drugs or products. 

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Guest Faculty Disclosures:

Unlabeled/Unapproved Uses:

Dr. Brown has indicated that there will be no references to the unlabeled or unapproved uses of any drugs or products. 

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: July 19, 2022
Expiration date: July 18, 2024

Start Issue